贝塔格宁通过诱导胰岛素分泌和β细胞增殖来改善糖尿病
Tomotaka Yokoo1, Kazuhisa Watanabe2, Kaoruko Iida3
1Division of Experimental Animal, Hidaka Branch, Biomedical Research Center, Saitama Medical University, Saitama, Japan; Research Center for Genomic Medicine, Saitama Medical University, Saitama, Japan.
The Journal of biological chemistry
|January 18, 2025
概括
研究人员发现了贝塔基宁,一种新的肠道激素,刺激胰岛素分泌,促进胰腺β细胞再生. 这一发现通过增强β细胞质量和功能,为糖尿病提供了潜在的新疗法.
科学领域:
- 内分泌学 在内分泌学.
- 胃肠病学 胃肠病学
- 代谢研究研究 代谢研究
背景情况:
- 人们越来越认识到肠道作为内分泌器官的作用,特别是在糖尿病治疗中GLP-1受体类似物和DPP-4抑制剂的成功.
- 肠道衍生激素如GLP-1,GIP和格林在调节能量代谢,食物摄入方面至关重要,并且与代谢综合征有关.
研究的目的:
- 为了隔离和描述一种新的肠道衍生激素,对糖尿病有潜在的治疗应用.
- 为了研究这种新激素贝塔基宁对胰岛素分泌,β细胞存活和再生的影响.
主要方法:
- 从肠道组织中分离和识别贝塔格宁.
- 使用胰腺小岛和MIN6细胞系进行体外研究,以评估胰岛素分泌和增殖.
- 在体内研究中,使用糖尿病 (链毒素诱导) 和转基因/淘汰赛小鼠的小鼠模型来评估贝塔格宁对血糖,HbA1c和β细胞质量的影响.
主要成果:
- 贝塔格宁被确定为一种新型的来自肠道的激素,可以刺激胰岛素分泌和β细胞增殖,同时抑制细胞亡.
- 在糖尿病小鼠中,腺病毒介导的贝塔基宁表达使血糖和HbA1c水平正常化,增加了β细胞质量.
- 转基因小鼠过度表达贝塔宁显示β细胞质量显著增加,而淘汰赛小鼠的质量减少.
- 合成的贝塔基宁增强了依赖葡萄糖的胰岛素分泌,并在体外和体内刺激了β细胞的增殖.
结论:
- 贝塔格宁是胰岛素分泌和β细胞再生的强有力的刺激剂.
- 这种肠道激素有望通过恢复β细胞功能和质量来开发新的治疗策略来控制糖尿病.
更多相关视频
相关概念视频
Glucagon-like Receptor Agonists
295
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
295
Insulin: Biosynthesis, Chemistry, and Preparation
349
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
349
Hormones Regulating Blood Glucose
3.0K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
3.0K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.1K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.1K
Dipeptidyl Peptidase 4 Inhibitors
165
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
165
Insulin Secretory Vesicles
4.8K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
4.8K


